Clinical Trials List
Protocol NumberEFC10832
2013-03-01 - 2015-05-31
Phase III
Terminated3
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- KO-JEN LI 風濕免疫科
- PING-NING HSU 風濕免疫科
- SONG-CHOU HSIEH 風濕免疫科
- 余家利 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
522 participants
